 |
|
|
|
|
|
 |
|
 Emisphere Technologies, Inc. pursues a strategy of seeking out and forming high-value, strategic partnerships with major pharmaceutical companies that have marketed products or have products in development that would benefit from our eligen® drug delivery technology. Emisphere can form multiple strategic alliances, and thus would not become dependent on any one product or company to achieve commercial success. By pursuing this strategy, Emisphere not only reduces its need for capital to get products to the marketplace, but also gains access to the active pharmaceutical ingredients, many of which are proprietary. This strategy reduces risk by diversification across multiple compounds.
For more information on the Emisphere®
Technology or partnership opportunities, please
contact the Business Development Department at
BusinessDevelopment@Emisphere.com |
|
|
|
|
|
|
|
